870 



GENERAL INDEX 



Thyroid preparations, in cretinism, 

 changes wrought by, in atrophied 

 thyroid gland, i, 88, 89. 

 mental, i, 89. 

 physical, i, 88. 



dosage, i, 90, 91. 



in exophthalmic goiter, i, 94. 



in goiter, i, 93. 



dosage, i, 94. 



- in hypothyroidism (myxredeme 

 fruste), i, 92. 



dosage, i, 93. 

 effects of, i, 93. 



in myxedema, i, 87. 



changes wrought by, i, 87. 

 dosage, i, 90, 91. 



i effect of, on atrophied thyroid 

 gland, i, 89. 



in obesity, i, 96. 



pharmachodynamic actions of, i, 86. 

 therapeutic employment of, i, 87. 



Thyroids, accessory, i, 40. 



Thyroid - sympathetic relationship, 

 clinical significance of, i, 171. 



Thyroid therapy, empiric and sympto- 

 matic, i, 98. 



in alopecia, i, 105. 



in affections of the skin, i, 104. 



in asthma, i, 102. 



in blood dyscrasias, i, 105. 

 in constipation, i, 102. 



in deafness, i, 102. 



in dementia precox, i, 101. 



in eczema, i, 105. 



in enuresis, i, 102. 



in epilepsy, i, 101. 



in epistaxis, i, 105. 



in hemophilia, i, 105. 



in ichthyosis, i, 105. 



in infectious diseases, i, 103. 



in mental diseases, i, 100. 



in purpura, i, 105. 



in scleroderma, i, 105. 



in syphilis, i, 103. 



in tetany, i, 100. 



of diseases of the bones (rickets), 



i, 99. 



of nephritis, i, 104. 



of rheumatism (articular and 



muscular), i, 99. 

 psoriasis, i, 104. 



for edema, 193. 



centra-indications to, iv, 193. 



indications for, iv, 193. 



Thyroid tissue, implantation of, in cre- 

 tinism and myxedema, i, 91. 



Thyroid transplantation, experiments 

 in, i, 238. 



Thyroid transplantation, in hypothy- 

 roidism, i, 433. 

 Thyroprotein, i, 253. 

 Thyrotoxicosis, i, 358. 



distinguished from hypothyroidism, 

 i, 380. 



Thyroxin, absorption and fate of, in in- 

 travenous injections, i, 85. 



action of, i, 232. 



analysis of, i, 232. 



analyzed and prepared, Kendall, i, 

 84. 



changing of, from one form to an- 

 other, i, 258. 



chemical properties of, i, 257. 



connection of, with internal secre- 

 tion of gland, i, 261. 



discovery of, i, 84. 



forms of, i, 256. 



amino-hydrate, i, 258. 



changes to open ring form, i, 256. 



forms of, changing from one to an- 

 other, i, 258. 



enol form, i, 258. 



keto form, i, 256, 257. 



open ring, i, 256, 258. 



hydrolysis of, i, 255. 



-Kendall's method, i, 256. 



isolation of, by Kendall, i, 254. 



nature and function of, i, 232. 



pharmacodynamic actions of, i, 86. 



propionic acid in, i, 256. 



qualitative test for, i, 258. 



represented by formula, i, 257. 



susceptibility of, to reduction rather 

 than to oxidation, i, 258. 



synthesis of, i, 259. 



terminology of, i, 6. 



therapeutic action of, i, 85. 



use of, in therapy, i, 943. 

 Timme's multiglandular syndrome, ii, 



409. 

 Tissue, term first employed by de Bor- 



deu, i, 46. 



Tissue fluid, iii, 788. 

 Tissue retention theory of gout, iv, 



442. 

 Tissues, action on, of light energy, iii, 



891.^ 



brain, iii, 467. 



connective, iii, 466. 



creatin content of, iii, 172. 



effect on, of roentgen rays and radio- 

 active substances, iii, 874. 



fate in, of amino-acids, iii, 105. 



fat in, changes in, iii, 206. 

 storing of, iii, 205. 



liver. See Liver, iii. 



